The Mark Foundation for Cancer Research in New York City has announced the winners of its 2020 Emerging Leader Awards.

Now in its second year, the program awarded grants totaling $4.5 million to six early-career investigators ready to take on risky, innovative projects with the potential to improve outcomes for cancer patients. This year's award recipients are Greg Delgoffe (University of Pittsburgh; "Improving Cancer Immunotherapy through Metabolic Modulation"); Philip Kranzusch (Dana-Farber Cancer Institute; "Mechanism of cGAS-STING Inactivation in Antitumor Immunity and Disease"); Amanda Lund (New York University; "Exploiting Lymphatic Transport for Early Detection"); Mario Suvà (Massachusetts General Hospital; "Targeting Cellular States and Plasticity in Glioblastoma"); Jeffrey Tyner (Oregon Health & Science University; "Drug Combinations to Preempt Resistance in AML"); and Eliezer Van Allen (Dana-Farber; "Convergence of Machine Learning and Translational Genomics for Prostate Cancer Precision Medicine").

"One of our top priorities as a foundation is to support the exciting work of the next generation of cancer research leaders," said Mark Foundation for Cancer Research CEO Michele Cleary. "We look forward to sustaining long-term partnerships with these exceptional scientists and are very eager for the results of their research to bring substantial benefits to cancer patients."